Potential of microneedles in enhancing delivery of photosensitising agents for photodynamic therapy

Photodiagnosis and Photodynamic Therapy

Volumn 11, Issue 4, 2014, Pages 459-466

  Kearney, Mary Carmel ^a   Brown, Sarah ^a   McCrudden, Maelíosa T C ^a   Brady, Aaron J ^a   Donnelly, Ryan F ^a  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

Author keywords

Microneedle; Photodynamic therapy; Photosensitiser; Preformed photosensitisers

Indexed keywords

AMINOLEVULINIC ACID; METHYL AMINOLAEVULINATE; PHOTOSENSITIZING AGENT; UNCLASSIFIED DRUG;

ARTICLE; DISSOLUTION; DRUG DELIVERY SYSTEM; HUMAN; HYDROGEL; HYDROPHILICITY; LIPOPHILICITY; MICRONEEDLE; MOLECULAR WEIGHT; PHOTODYNAMIC THERAPY; PHYSICAL CHEMISTRY; DEVICE FAILURE ANALYSIS; DEVICES; ELECTRONICS; EQUIPMENT DESIGN; FEASIBILITY STUDY; MICROFLUIDICS; MICROINJECTION; NEEDLE; PHOTOCHEMOTHERAPY;

EQUIPMENT DESIGN; EQUIPMENT FAILURE ANALYSIS; FEASIBILITY STUDIES; MICROFLUIDICS; MICROINJECTIONS; MINIATURIZATION; NEEDLES; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS;

EID: 84918833494     PISSN: 15721000     EISSN: 18731597     Source Type: Journal    
DOI: 10.1016/j.pdpdt.2014.09.003     Document Type: Article

References (56)

1. Patrice T., Moan J., Peng Q. An outline in the history of PDT. Photodyn. Ther. 2003, 1-18. Royal Society of Chemistry, Cambridge.
2. Berg K. Basic principles of 5-aminolevulinic acid-based photodynamic therapy. Photodyn. Ther. Fluoresc. Diagnosis Dermatology 2001, vol. 2:115-143. Elsevier Science B.V.
3. Krammer B., Plaetzer K. ALA and its clinical impact, from bench to bedside. Photochem Photobiol Sci 2008, 7:283-289.
4. Morton C.A., Szeimies R-M., Sidoroff A., Braathen L.R. European guidelines for topical photodynamic therapy part 1: treatment delivery and current indications - actinic keratoses, Bowen's disease, basal cell carcinoma. J Eur Acad Dermatol Venereol 2013, 27:536-544.
5. Donnelly R., McCarron P.A., Zawislak A., Woolfson D.A. Chapter 1: photodynamic therapy. Photodyn. Ther. Vulval Neoplasias Dysplasias - Des. Eval. Bioadhesive Photosensit. Deliv. Syst. 2009, 6-70. VDM Publishing.
6. Yano S., Hirohara S., Obata M., Hagiya Y., Ogura S., Ikeda A., et al. Current states and future views in photodynamic therapy. J Photochem Photobiol C Photochem Rev 2011, 12:46-67.
7. Kennedy J.C. Introduction. Photodyn Ther. with ALA A Clin. Handb. 2006, vol. 137:1-14. The Royal Society of Chemistry, Cambridge.
8. Berg K. Basic principles of 5-aminolevulinic acid-based photodynamic therapy. Photodyn. Ther. Fluoresc. Diagnosis Dermatology 2001, 115-143. Elsevier Science B. V.
9. Donnelly R.F., Morrow D.I.J., Fay F., Scott C.J., Abdelghany S., Singh R.R.T., et al. Microneedle-mediated intradermal nanoparticle delivery: potential for enhanced local administration of hydrophobic pre-formed photosensitisers. Photodiagnosis Photodyn Ther 2010, 7:222-231.
10. Castano A.P., Demidova T.N., Hamblin M.R. Mechanisms in photodynamic therapy: part one - photosensitizers, photochemistry and cellular localization. Photodiagn Photodyn Ther 2004, 1:279-293.
11. Morton C.A., Brown S.B., Collins S., Ibbotson S., Jenkinson H., Kurwa H., et al. Guidelines for topical photodynamic therapy: report of a workshop of the British Photodermatology Group. Br J Dermatol 2002, 146:552-567.
12. Donnelly R.F., Morrow D.I.J., McCarron P.A., Woolfson A.D., Morrissey A., Juzenas P., et al. Microneedle-mediated intradermal delivery of 5-aminolevulinic acid: potential for enhanced topical photodynamic therapy. J Control Release 2008, 129:154-162.
13. Zhang L-W., Fang Y-P., Fang J-Y. Enhancement techniques for improving 5-aminolevulinic acid delivery through the skin. Dermatol Sin 2011, 29:1-7.
14. Morton C.A., MacKie R.M., Whitehurst C., Moore J.V., McColl J.H. Photodynamic therapy for basal cell carcinoma: effect of tumour thickness and duration of photosensitiser application on response. Arch Dermatol 1998, 134:248-249.
15. Donnelly R.F., Juzenas P., McCarron P.A., Ma L-W., Woolfson A.D., Moan J. Influence of formulation factors on methyl-ALA-induced protoporphyrin IX accumulation in vivo. Photodiagn Photodyn Ther 2006, 3:190-201.
16. Tuan-Mahmood T-M., McCrudden M.T.C., Torrisi B.M., McAlister E., Garland M.J., Singh T.R.R., et al. Microneedles for intradermal and transdermal drug delivery. Eur J Pharm Sci 2013, 50:623-637.
17. Arora A., Prausnitz M.R., Mitragotri S. Micro-scale devices for transdermal drug delivery. Int J Pharm 2008, 364:227-236.
18. Gratieri T., Alberti I., Lapteva M., Kalia Y.N. Next generation intra- and transdermal therapeutic systems: using non- and minimally-invasive technologies to increase drug delivery into and across the skin. Eur J Pharm Sci 2013, 50:609-622.
19. Henry S., McAllister D., Allen M., Prausnitz M. Microfabricated microneedles: a novel approach to transdermal drug delivery. J Pharm Sci 1999, 88:948.
20. Donnelly R.F., Mccarron P.A., Woolfson A.D. Drug delivery of aminolevulinic acid from topical formulations intended for photodynamic therapy. Photochem Photobiol 2005, 75:0-6. 7.
21. Kuijpers D., Thissen M., Thissen C., Neumann M. Similar effectiveness of methyl aminolevulinate and 5-aminolevulinate in topical photodynamic therapy for nodular basal cell carcinoma. J Drug Dermatol 2006, 5:642-645.
22. Morrow D.I.J., Mccarron P.A., Woolfson A.D., Juzenas P., Juzeniene A., Iani V., et al. Hexyl aminolaevulinate is a more effective topical photosensitiser precursor than methyl aminolaevulinate and 5-aminolaevulinic acids when applied in equimolar doses. J Pharm Sci 2010, 99:3486-3498.
23. Donnelly R.F., Morrow D.I.J., McCrudden M.T.C., Alkilani A.Z., Vicente-Pérez E.M., O'Mahony C., et al. Hydrogel-forming and dissolving microneedles for enhanced delivery of photosensitizers and precursors. Photochem Photobiol 2013, 90:641-647.
24. Donnelly R.F., Morrow D.I.J., Mccarron P.A., Woolfson A.D., Morrissey A., Juzenas P., et al. Microneedle arrays permit enhanced intradermal delivery of a preformed photosensitizer. Photochem Photobiol 2009, 85:195-204.
25. Donnelly R.F., Morrow D.I.J., McCarron P.A., Garland M.J., Woolfson A.D. Influence of solution viscosity and injection protocol on distribution patterns of jet injectors: application to photodynamic tumour targeting. J Photochem Photobiol B 2007, 89:98-109.
26. Wang S., Fan W., Kim G., Hah H.J., Lee Y-E.K., Kopelman R., et al. Novel methods to incorporate photosensitizers into nanocarriers for cancer treatment by photodynamic therapy. Lasers Surg Med 2011, 43:686-695.
27. Morrow D.I.J., McCarron P.A., Woolfson A.D., Juzenas P., Juzeniene A., Iani V., et al. Influence of penetration enhancers on topical delivery of 5-aminolevulinic acid from bioadhesive patches. J Pharm Pharmacol 2010, 62:685-695.
28. Juzeniene A., Juzenas P., Ma L-W., Iani V., Moan J. Topical application of 5-aminolaevulinic acid, methyl 5-aminolaevulinate and hexyl 5-aminolaevulinate on normal human skin. Br J Dermatol 2006, 155:791-799.
29. Moan J., Ma L-W., Juzeniene A., Iani V., Juzenas P., Apricena F., et al. Pharmacology of protoporphyrin IX in nude mice after application of ALA and ALA esters. Int J Cancer 2003, 103:132-135.
30. Ko D-Y., Kim K-H., Song K-H. Comparative study of photodynamic therapy with topical methyl aminolevulinate versus 5-aminolevulinic acid for facial actinic keratosis with long-term follow-up. Ann Dermatol 2014, 26:321-331.
31. Morrow D.I.J., McCarron P.A., Woolfson A.D., Juzenas P., Juzeniene A., Iani V., et al. Novel patch-based systems for the localised delivery of ALA-esters. J Photochem Photobiol B 2010, 101:59-69.
32. Donnelly R.F., Cassidy C.M., Loughlin R.G., Brown A., Tunney M.M., Jenkins M.G., et al. Delivery of Methylene Blue and meso-tetra (N-methyl-4-pyridyl) porphine tetra tosylate from cross-linked poly(vinyl alcohol) hydrogels: a potential means of photodynamic therapy of infected wounds. J Photochem Photobiol B 2009, 96:223-231.
33. De Rosa F.S., Tedesco A.C., Lopez R.F.V., Riemma Pierre M.B., Lange N., Marchetti J.M., et al. In vitro skin permeation and retention of 5-aminolevulinic acid ester derivatives for photodynamic therapy. J Control Release 2003, 89:261-269.
34. Donnelly R.F., McCarron P.A., Lightowler J.M., Woolfson A.D. Bioadhesive patch-based delivery of 5-aminolevulinic acid to the nail for photodynamic therapy of onychomycosis. J Control Release 2005, 103:381-392.
35. Fallows S.J., Garland M.J., Cassidy C.M., Tunney M.M., Singh T.R.R., Donnelly R.F. Electrically-responsive anti-adherent hydrogels for photodynamic antimicrobial chemotherapy. J Photochem Photobiol B 2012, 114:61-72.
36. Krishnan G., Grice J.E., Roberts M.S., Benson H.A., Prow T.W. Enhanced sonophoretic delivery of 5-aminolevulinic acid: preliminary human ex vivo permeation data. Skin Res Technol 2013, 19:e283-e289.
37. Clementoni M.T., B-Roscher M., Munavalli G.S. Photodynamic photorejuvenation of the face with a combination of microneedling, red light, and broadband pulsed light. Lasers Surg Med 2010, 42:150-159.
38. Mikolajewska P., Donnelly R.F., Garland M.J., Morrow D.I.J., Singh T.R.R., Iani V., et al. Microneedle pre-treatment of human skin improves 5-aminolevulininc acid (ALA)- and 5-aminolevulinic acid methyl ester (MAL)-induced PpIX production for topical photodynamic therapy without increase in pain or erythema. Pharm Res 2010, 27:2213-2220.
39. Park J-H., Allen M.G., Prausnitz M.R. Polymer microneedles for controlled-release drug delivery. Pharm Res 2006, 23:1008-1019.
40. Prausnitz M.R. Microneedles for transdermal drug delivery. Adv Drug Deliv Rev 2004, 56:581-587.
41. Gomaa Y.A., Morrow D.I.J., Garland M.J., Donnelly R.F., El-Khordagui L.K., Meidan V.M. Effects of microneedle length, density, insertion time and multiple applications on human skin barrier function: assessments by transepidermal water loss. Toxicol Vitr 2010, 24:1971-1978.
42. Donnelly R.F., Singh T.R.R., Alkilani A.Z., McCrudden M.T.C., O'Neill S., O'Mahony C., et al. Hydrogel-forming microneedle arrays exhibit antimicrobial properties: potential for enhanced patient safety. Int J Pharm 2013, 451:76-91.
43. Kolde G., Rowe E., Meffert H. Optimization of the photodynamic therapy by microneedle perforation. J Der Dtsch Dermatologischen Gesellschaft 2011, 9.
44. Kolde G., Rowe E., Meffert H. Effective photodynamic therapy of actinic keratoses and Bowen's disease using microneedle perforation. Br J Dermatol 2013, 168:450-452.
45. Lee J.W., Yoo K.H., Kim B.J., Kim M.N. Photodynamic therapy with methyl 5-aminolevulinate acid combined with microneedle treatment in patients with extensive alopecia areata. Clin Exp Dermatol 2010, 35:548-549.
46. Aust M.C., Fernandes D., Kolokythas P., Kaplan H.M., Vogt P.M. Percutaneous collagen induction therapy: an alternative treatment for scars, wrinkles, and skin laxity. Plast Reconstr Surg 2008, 121:1421-1429.
47. Majid I. Microneedling therapy in atrophic facial scars: an objective assessment. J Cutan Aesthet Surg 2009, 2:26.
48. Park K.Y., Kim H.K., Kim S.E., Kim B.J., Kim M.N. Treatment of striae distensae using needling therapy: a pilot study. Dermatol Surg 2012, 38:1823-1828.
49. Donnelly R.F., Singh T.R.R., Morrow D.I.J., Woolfson A.D. Microneedle-mediated transdermal and intradermal drug delivery 2012, John Wiley & Sons, Ltd., Chichester, UK.
50. Quinn H.L., Kearney M.-C., Courtenay A.J., McCrudden M.T., Donnelly R.F. The role of microneedles for drug and vaccine delivery. Expert Opin Drug Deliv 2014, 10.1517/17425247.2014.938635.
51. Park J.-H., Allen M.G., Prausnitz M.R. Biodegradable polymer microneedles: fabrication, mechanics and transdermal drug delivery. J Control Release 2005, 104:51-66.
52. Lev-Tov H., Larsen L., Zackria R., Chahal H., Eisen D., Sivamani R., et al. Microneedle pretreatment may reduce incubation time in photodynamic therapy. J Invest Dermatol 2013, 133:S180.
53. Donnelly R.F., Morrow D.I.J., Singh T.R.R., Migalska K., McCarron P.A., O'Mahony C., et al. Processing difficulties and instability of carbohydrate microneedle arrays. Drug Dev Ind Pharm 2009, 35:1242-1254.
54. Demir Y.K., Akan Z., Kerimoglu O. Characterization of polymeric microneedle arrays for transdermal drug delivery. PLOS ONE 2013, 8:e77289.
55. Donnelly R.F., Singh T.R.R., Garland M.J., Migalska K., Majithiya R., McCrudden C.M., et al. Hydrogel-forming microneedle arrays for enhanced transdermal drug delivery. Adv Funct Mater 2012, 22:4879-4890.
56. Donnelly R.F., Woolfson A.D. Patient safety and beyond: what should we expect from microneedle arrays in the transdermal delivery arena?. Ther Deliv 2014, 5:1-10.